Posted by Clinical Lab Products | Jul 15, 2009 | Cancer, Molecular Diagnostics |
Abbott and GlaxoSmithKline (GSK) will develop an automated molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for expression of the MAGE-A3 antigen.
Read MorePosted by Clinical Lab Products | Jul 9, 2009 | Cancer, Miscellaneous |
AMDL Inc a US-based pharmaceutical company with major operations in China, announced today the launch of a new brand name for its DR-70 (FDP) in vitro diagnostic cancer test. With today’s announcement, AMDL will manufacture, market, and sell DR-70 under the brand name Onko-Sure.
Read MorePosted by Clinical Lab Products | Jun 23, 2009 | Cancer, Miscellaneous |
Exosome Diagnostics Inc and DxS Ltd today announced that they will collaborate on the development of blood based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR.
Read MorePosted by Clinical Lab Products | Jun 11, 2009 | Cancer, Miscellaneous |
SCC Soft Computer announces that their SoftPath synoptic reporting tool has been certified by Cancer Care Ontario.
Read MorePosted by Clinical Lab Products | May 28, 2009 | Cancer, Miscellaneous |
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.
Read More